Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News EOM Pharmaceutical Holdings Inc IMUC

Healthcare Biotechnology
EOM Pharmaceutical Holdings, Inc. is a clinical-stage pharmaceutical company. The Company is focused on developing novel drugs for patients suffering from debilitating and deadly diseases, including infectious diseases; autoimmune diseases including rheumatoid arthritis; and cachexia associated with acquired immune deficiency syndrome (AIDS) and cancer. It has two pipeline assets in their... see more

Recent & Breaking News (PINL:IMUC)

Squawk Box Stocks Reports On: Opexa Therapeutics, Inc. (NASDAQ: OPXA), ImmunoCellular Therapeutics, Ltd. (NYSE MKT: IMUC), Protalix BioTherapeutics, Inc. (NYSE MKT: PLX), Titan Pharmaceuticals Inc. (OTCQB: TTNP).

Marketwired February 6, 2013

ImmunoCellular Therapeutics to Present at BIO CEO & Investor Conference on February 11th

Business Wire February 4, 2013

ImmunoCellular Therapeutics' Investigational New Drug (IND) Application for ICT-140 Allowed by the FDA

Business Wire January 29, 2013

Major Revenue Losses From Patent Expirations Forces Big Pharma Companies to Look to the Biotech Industry for Replacements

Marketwired January 17, 2013

ImmunoCellular Therapeutics Provides Update on Corporate Milestones

Business Wire January 7, 2013

ImmunoCellular Therapeutics Appoints Gary S. Titus to its Board of Directors

Business Wire January 2, 2013